Viking Therapeutics
  • Home
  • About
    • Overview
    • Management
    • Board of Directors
    • Careers
  • Pipeline
    • Overview
    • Metabolic Disease Programs
      • VK2809 (NASH)
      • VK2735 (Metabolic Disorders)
    • Rare Disease Program
      • VK0214 (X-ALD)
    • Other Pipeline Programs
      • VK5211 (Hip Fracture, Muscle Wasting)
      • VK0612 (Type 2 Diabetes)
      • VK1430 (Hypertriglyceridemia, NASH)
      • EPOR Agonist Program (Anemia)
  • Investors & Media
    • Overview
    • Stock Information
    • News & Events
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Shareholder Services
    • Corporate Presentation
  • Contact

    Stock Information

    Investors

    • Overview
    • Stock Information
      • Stock Chart
      • Historical Price Lookup
      • Stock Calculator
    • News & Events
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Shareholder Services
    • Corporate Presentation

    NASDAQVKTX
    $12.88
    NASDAQVKTX
    Open
    $13.37
    Change
    -$0.43 (-3.23%)
    Day's Range
    $12.77 - $13.51
    52-Week Range
    $2.53 - $25.72
    Volume
    1.9M
    Market Cap
    $1.3B
    Currency in USD.
    Quote data delayed by at least 15 minutes.

     

     

    viking therapeutics

    About

    Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.

    Contact

    General Information
    Business Development
    ©2023 Viking Therapeutics
    Terms of Use
    Privacy Policy